Cabaletta Bio | SC 13G/A:超过5%持股股东披露文件(修正)-Alger Associates, Inc.(2.7%)
Cabaletta Bio | SC 13G/A:超过5%持股股东披露文件(修正)
Cabaletta Bio | SC 13G/A:超过5%持股股东披露文件(修正)-Jennison Associates LLC(5.1%)
Cabaletta Bio | 8-K:重大事件
Cabaletta Bio | SC 13G/A:超过5%持股股东披露文件(修正)-Venrock Healthcare Capital Partners III, L.P.(3.3%),VHCP Co-Investment Holdings III, LLC(3.3%)等
Cabaletta Bio | SC 13G/A:超过5%持股股东披露文件(修正)-Alger Associates, Inc.(8.4%)
Cabaletta Bio | SC 13G:超过5%持股股东披露文件-T. Rowe Price Investment Management, Inc.(7.5%)
Cabaletta Bio | 10-Q:2024财年三季报
Cabaletta Bio | 8-K:Cabaletta Bio公布2024年第三季度财务业绩并提供业务最新情况
Cabaletta Bio | SC 13G/A:超过5%持股股东披露文件(修正)-The Vanguard Group(5.22%)
Cabaletta Bio | SC 13G/A:超过5%持股股东披露文件(修正)-Adage Capital Management, L.P.(7.43%),Robert Atchinson(7.43%)等
Cabaletta Bio | SC 13G/A:超过5%持股股东披露文件(修正)-The Vanguard Group(5.22%)
Cabaletta Bio | SC 13G/A:超过5%持股股东披露文件(修正)-The Vanguard Group(5.22%)
Cabaletta Bio | SC 13G/A:超过5%持股股东披露文件(修正)-The Vanguard Group(5.22%)
Cabaletta Bio | SC 13G/A:超过5%持股股东披露文件(修正)-STATE STREET CORPORATION :(1.8%)
Cabaletta Bio | 8-K:重大事件
Cabaletta Bio | 8-K:重大事件
Cabaletta Bio | SC 13G:超过5%持股股东披露文件-Bain Capital Life Sciences Opportunities III, LP(5.7%)
Cabaletta Bio | 10-Q:2024财年二季报
Cabaletta Bio | 8-K:Cabaletta Bio公布2024年第二季度财务业绩并提供业务最新情况